# Travere Therapeutics (TVTX) — Overview

TVTX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/tvtx

## Price

Last close $53.08 on Oct 15, 2026. 52-week range $26.14 – $67.52.

## Company profile

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease. It is also advancing pegtibatinase, a novel investigational enzyme replacement therapy for the treatment of HCU, a genetic disorder caused by a deficiency in a pivotal enzyme essential to the body.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $591.3M |
| Revenue (quarter) | $169.6M |
| Revenue growth (year over year) | 48.17% |
| Gross profit (trailing twelve months) | $583.1M |
| Gross margin | 98.60% |
| Net income (trailing twelve months) | −$43.5M |
| Net income (quarter) | −$34.8M |
| Net income growth (year over year) | -172.81% |
| Net margin | -7.35% |
| Return on equity | -151.79% |
| EPS (trailing twelve months) | −$0.46 |
| Book value per share | $0.26 |
| P/E (trailing twelve months) | — |
| Price to book | 202.8 |
| Debt to assets | 96.93% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Travere Therapeutics (TVTX) profitable?

No. Travere Therapeutics reported a net loss of $43.5M over the trailing twelve months.

### How much revenue does Travere Therapeutics (TVTX) make?

Travere Therapeutics generated $591.3M in revenue over the trailing twelve months, up 48.17% year over year.

### How do I buy stock in Travere Therapeutics (TVTX)?

TVTX trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).